1-3 of 3
Ryo Ito
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

2060-P: RFX6, a Causative Gene of Mitchell-Riley Syndrome, Regulates ParaHox Genes in Early Endodermal Differentiation

TOSHIHIRO NAKAMURA, JUNJI FUJIKURA, RYO ITO, NOBUYA INAGAKI
Journal: Diabetes
Diabetes 2020;69(Supplement_1):2060-P
https://doi.org/10.2337/db20-2060-P
Published: 01 June 2020
View article titled, 2060-P: RFX6, a Causative Gene of Mitchell-Riley Syndrome, Regulates ParaHox Genes in Early Endodermal Differentiation
Journal Articles

Insulin-Deficient Diabetic Condition Upregulates the Insulin-Secreting Capacity of Human Induced Pluripotent Stem Cell–Derived Pancreatic Endocrine Progenitor Cells After Implantation in Mice

Taisuke Mochida, Hikaru Ueno, Noriko Tsubooka-Yamazoe, Hideyuki Hiyoshi, Ryo Ito, Hirokazu Matsumoto, Taro Toyoda
Journal: Diabetes
Diabetes 2020;69(4):634–646
https://doi.org/10.2337/db19-0728
Published: 31 January 2020
View article titled, Insulin-Deficient Diabetic Condition Upregulates the Insulin-Secreting Capacity of Human Induced Pluripotent Stem Cell–Derived Pancreatic Endocrine Progenitor Cells After Implantation in Mice
Open the PDF for Insulin-Deficient Diabetic Condition Upregulates the Insulin-Secreting Capacity of Human Induced Pluripotent Stem Cell–Derived Pancreatic Endocrine Progenitor Cells After Implantation in Mice in another window
Includes: Supplementary data
Meeting Abstracts

1161-P: SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control More Than That by Fasiglifam in Rat Models of Diabetes and Obesity

YUSUKE MORITOH, HIKARU UENO, RYO ITO, SHIN-ICHI ABE, HIROHISA MIYASHITA, HITOMI OGINO, MITSUGI OOKAWARA, YOSHIMASA ISHIMURA, YASUFUMI MIYAMOTO, TOMOKI YOSHIHARA, YOSHIYUKI TSUJIHATA, KOJI TAKEUCHI, NOBUHIRO NISHIGAKI, YUKIO YAMADA, MASANORI WATANABE
Journal: Diabetes
Diabetes 2019;68(Supplement_1):1161-P
https://doi.org/10.2337/db19-1161-P
Published: 01 June 2019
View article titled, 1161-P: SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control More Than That by Fasiglifam in Rat Models of Diabetes and Obesity